In this week’s issue:
- Technology Evaluation in the Elderly Network – Catalyst Grant Program
- American Association for Cancer Research/American Cancer Society/Stand Up to Cancer – Stand Up to Cancer-American Cancer Society Lung Cancer Translational Research Dream Team Grant
- Alzheimer Society – Alzheimer Society Research Program
- MITACS – Globalink Research Award – Inria
- CIHR – SPOR Networks in Chronic Disease
- UBC Faculty of Medicine – Career Day (final reminder)
- Michael Smith Laboratories Seminar – Conquering the Barriers: Antibodies as Therapeutic Agents for Diseases of the Central Nervous System
- SPARC – CIHR New Investigator Salary Award workshop
- First International Conference on Weaver Syndrome (reminder)
LOI Deadline: October 17, 2014; 9am
Application Deadline: October 31, 2014; 9am
Technology Evaluation in the Elderly Network (TVN) is offering funding to catalyze creativity, novelty, and innovation in research to benefit Canada’s seriously ill, frail elderly.
The Catalyst Grant Program will fund projects of up to one (1) year in length and normally up to $100,000 each. For projects of exceptional merit and with adequate justification, there may be an opportunity to increase the budget to $150,000.
Catalyst Grants will support scalable research studies including pilot studies, feasibility studies, translation studies and novel and innovative approaches aligned with TVN strategic priorities and patient-centred research themes, and that demonstrate knowledge translational capacity aimed at improving care for the seriously ill elderly. For this competition, projects will be prioritized that are:
- demonstration projects aiming to investigate system changes for the benefit of the seriously ill, frail elderly, or
- knowledge mobilization projects that seek to improve the update or application of existing evidence to improve the care of the seriously ill, frail elderly.
As a national network, TVN seeks to support cross-provincial research teams from multiple disciplines and multiple institutions in funding research projects that fill gaps and address questions that would not normally be funded by existing agencies. Catalyst Grant projects are expected to be actively managed and have high requirements for partnerships, HQP and engagement with stakeholders and knowledge users.
Please visit the TVN website for additional information.
LOI Deadline: November 5, 2014
The American Association for Cancer Research, in partnership with the American Cancer Society and Stand Up to Cancer, has issued a Request for Proposals for the Stand Up to Cancer-American Cancer Society Lung Cancer Translational Research Dream Team Grant.
The initiative aims to advance lung cancer research through the creation of a collaborative, translational, research “Dream Team” featuring talented and promising researchers with the expertise needed to solve key problems in lung cancer. The team will span multiple disciplines and institutions and will utilize the new tools of modern biology to attack research questions in a coordinated way.
To that end, AACR will award up to $20 million over three years in support of a translational cancer research project that addresses critical problems in lung cancer and positively impacts patients in the near future. The project should include new immunological approaches to and therapeutic interventions for lung cancer and have the potential to deliver near-term patient benefit through investigation by a multidisciplinary, multi-institutional team of expert investigators.
To maximize creativity, innovation and collaboration, the research team must include laboratory and clinical researchers, senior and/or young investigators, and senior scientists who have not worked together in the past.
Letters of intent must be received no later than November 5, 2014. Upon review, selected applicants will be invited to submit complete proposals sometime in December; they will be due on February 2, 2014.
For complete program guidelines and application procedures, visit the AACR website.
Deadline: November 28, 2014
The Alzheimer Society Research Program is a collaborative initiative of the provincial Alzheimer Societies, the Alzheimer Society of Canada, partners, and our valuable donors who support research directed at both eradicating dementia and improving the lives of those affected by it.
As of 2014, the Alzheimer Society Research Program (ASRP) has funded over $43 million in grants and awards since its inception in 1989. The ASRP targets two types of research:
- Biomedical: Focusing on the science of the brain and the changes that are associated with dementia and identifying therapeutic targets to reverse, stop or cure the disease
- Quality of Life (QoL): Exploring issues that impact the lives of people with dementia and their caregivers, including risk factors, behavioural and cognitive changes, physical support, caregiving and health service delivery
The ASRP offers a variety of funding types, including Doctoral, Postdoctoral, New Investigator/Career Change Grants, and Research Grants.
Please visit the ASRP website for further details.
Deadline: December 1, 2014; 5pm
The Mitacs Globalink Research Award – Inria is an exciting new competitive initiative that provides the opportunity for faculty members and graduate students at Canadian universities to build an international research network and undertake research abroad at Inria Research Centres.
The Globalink Research Award – Inria offers graduate students at Mitacs full and associate partner universities in Canada the opportunity to participate in 12– to 24–week research projects supervised by a recognized research member at Inria.
Inria is dedicated to fundamental and applied research in information and communication science and technology and is organized around five main fields of research:
- Applied mathematics, computation and simulation
- Algorithmic, programming, software and architecture
- Networks, systems and services, distributed computing
- Perception, cognition, interaction
- Digital Health, Biology and Earth
The call for applications will open on September 30, 2014 and will close on December 1, 2014 at 5 p.m. PST. This is a competitive call and a limited number of awards are available. Successful applicants can begin their Research Award as early as March 2nd 2015 and as late as December 31st 2015.
CIHR – SPOR Networks in Chronic Disease
Funding Opportunity Launch: October 2014
Registration Deadline: December 2, 2014
LOI Deadline: January 6, 2015
Application Deadline: October 15, 2015
In October 2014, the Canadian Institutes of Health Research as a partner in the Strategy for Patient-Oriented Research (SPOR) will launch the SPOR Networks in Chronic Disease funding opportunity. This funding opportunity will provide support for the development and implementation of SPOR Networks in non-communicable Chronic Diseases. For the purpose of this opportunity, non-communicable chronic disease is defined as a long-term disease that is not passed from one person to another; it evolves over time, often progressing in severity. Although a non-communicable chronic disease may be prevented and can often be controlled, it is rarely cured.
The primary objective of the opportunity will be to translate existing and new knowledge generated by basic biomedical, clinical, and population health research into testing of innovations that can improve clinical science and practice and foster policy changes, leading to transformative and measureable improvements in patient health outcomes, and in efficiency and effectiveness of healthcare delivery within five years.
Total funding available from CIHR for this initiative is $50.8M:
- $1.0M will be available to fund up to 20 Development Grants through the Letter of Intent stage of this opportunity. Each Development Grant will have a maximum value of $50,000. Partner funds are NOT required at this stage.
- $49.8M will be available to fund up to four distinct networks. Each successful network will receive up to $12,450,000 over five years from CIHR and must be matched at a minimum of 1:1 with funding from non-federal sources. Partner funds ARE required at the full application stage.
Visit the CIHR website for the official funding opportunity launch and information webinars. Please contact Erica Dobson (SPOR-SRAP@cihr-irsc.gc.ca) for more information.
Date & Time: October 8, 2014; 2:30-6pm
Location: Graduate Student Ballroom, Thea Koerner House, 225-6371 Crescent Road, Vancouver
Registration is now open for the UBC Faculty of Medicine – Career Day 2014.
On October 8th, 30 Career Experts will be present to engage in small group discussions with postdoctoral fellows and senior graduate students in the UBC Faculty of Medicine. There is no charge to attend.
2:30 – 3:00pm – Registration
3:00 – 5:00pm – Small group sessions with Career Experts
5:00 – 6:00pm – Networking, with light food and beverages provided
There is limited space available, and registration is on a first-come first-served basis. Registration and speaker biographies are available at the following website: https://careerday.hli.ubc.ca/apex/f?p=140503:1:0
This free event is being brought to you by the Faculty of Medicine Postdoctoral Professional Development Team.
Michael Smith Laboratories Seminar – Conquering the Barriers: Antibodies as Therapeutic Agents for Diseases of the Central Nervous System
Date & Time: October 8, 2014; 3-4pm
Location: MSL Auditorium, Rm 102
Seminar presented by:
Danica B. Stanimirovic, PhD
Research Director, National Research Council of Canada
Adjunct Professor, Department of Cellular and Molecular Medicine, University of Ottawa
Date & Time: October 10, 2014; 9am-12pm
Location: UBC Point Grey campus, room TBD
SPARC is hosting its annual CIHR New Investigator Salary Award workshop on Friday, October 10th from 9am to 12pm at the UBC Point Grey campus. For more information and to register, please visit the following webpage: http://research.ubc.ca/civicrm/event/info?reset=1&id=118
Please also visit SPARC’s Sample Grant Library (CWL required) to view successful 2013 and 2012 applications. Note: New 2013 grants will be added as they are made available. Thank you to our CIHR New Investigators for generously sharing copies of their successful applications.
Date & Time: November 9, 2014, 9am-6pm
Location: Hyatt Regency Vancouver, 655 Burrard St, Vancouver
It is with great pleasure that we announce the First International Conference on Weaver Syndrome, to take place Sunday, November 9th, 2014 at the Hyatt Regency Hotel, Vancouver.
The conference is intended to be of interest to families affected by Weaver syndrome and related overgrowth conditions, as well as to physicians, scientists and academic trainees with an interest in Weaver syndrome, genetic and epigenetic overgrowth syndromes, and rare disorders in general.
It will be a satellite meeting the day following the Canadian College of Medical Geneticists’
annual meeting (scheduled for November 6-8, 2014), on the same site as the CCMG meeting (i.e. at the Hyatt Regency Hotel, Vancouver).
Professor David Weaver (First to describe the syndrome that now bears his name) Topic: Historical Retrospective of the Description of Weaver syndrome and clinical overview of features
Dr. Steven JM Jones (Head of Bioinformatics, Michael Smith Genome Sciences Centre) Topic: Next-generation sequencing methods for gene discovery and diagnosis
Dr. Serena Buontempo (Stem Cell specialist from Italy) Topic: Stem Cells – Lessons from EZH2-mutant cell lines and applications for Weaver syndrome
There will also be 3-4 trainee talks for graduate students and postdoctoral fellows.
The current schedule is for 3 talks in the morning 9am-12pm, lunch break for 1 hour then talks 2pm-3pm with trainee talks 3pm-4pm and then a family event.
Tickets are free for the scientific portion of the conference. There may be a separate fee for the family social event afterwards. Registration is available here:
If you do not wish to use the Eventbrite service, please contact the organizer, Dr. William Gibson, to register.